Literature DB >> 25091347

A new structurally atypical bradykinin-potentiating peptide isolated from Crotalus durissus cascavella venom (South American rattlesnake).

Denise M Lopes1, Norberto E G Junior1, Paula P C Costa1, Patrícia L Martins1, Cláudia F Santos1, Ellaine D F Carvalho2, Maria D F Carvalho3, Daniel C Pimenta4, Bruno A Cardi5, Manassés C Fonteles1, Nilberto R F Nascimento1, Krishnamurti M Carvalho6.   

Abstract

Venom glands of some snakes synthesize bradykinin-potentiating peptides (BPP's) which increase bradykinin-induced hypotensive effect and decrease angiotensin I vasopressor effect by angiotensin-converting enzyme (ACE) inhibition. The present study shows a new BPP (BPP-Cdc) isolated from Crotalus durissus cascavella venom: Pro-Asn-Leu-Pro-Asn-Tyr-Leu-Gly-Ile-Pro-Pro. Although BPP-Cdc presents the classical sequence IPP in the C-terminus, it has a completely atypical N-terminal sequence, which shows very low homology with all other BPPs isolated to date. The pharmacological effects of BPP-Cdc were compared to BBP9a from Bothrops jararaca and captopril. BPP-Cdc (1 μM) significantly increased BK-induced contractions (BK; 1 μM) on the guinea pig ileum by 267.8% and decreased angiotensin I-induced contractions (AngI; 10 nM) by 62.4% and these effects were not significantly different from those of BPP9a (1 μM) or captopril (200 nM). Experiments with 4-week hypertensive 2K-1C rats show that the vasopressor effect of AngI (10 ng) was decreased by 50 μg BPP-Cdc (69.7%), and this result was similar to that obtained with 50 μg BPP9a (69.8%). However, the action duration of BPP-Cdc (60 min) was 2 times greater than that of BPP-9a (30 min). On the other hand, the hypotensive effect of BK (250 ng) was significantly increased by 176.6% after BPP-Cdc (50 μg) administration, value 2.5 times greater than that obtained with BPP9a administered at the same doses (71.4%). In addition, the duration of the action of BPP-Cdc (120 min) was also at least 4 times greater than that of BPP-9a (30 min). Taken together, these results suggest that BPP-Cdc presents more selective action on arterial blood system than BPP9a. Besides the inhibition of ACE, it may present other mechanisms of action yet to be elucidated.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiotensin-converting enzyme; Bradykinin-potentiating peptide; Crotalus durissus cascavella venom; Hypertension

Mesh:

Substances:

Year:  2014        PMID: 25091347     DOI: 10.1016/j.toxicon.2014.07.011

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  7 in total

1.  Rapid screening and identification of ACE inhibitors in snake venoms using at-line nanofractionation LC-MS.

Authors:  Marija Mladic; Tessa de Waal; Lindsey Burggraaff; Julien Slagboom; Govert W Somsen; Wilfried M A Niessen; R Manjunatha Kini; Jeroen Kool
Journal:  Anal Bioanal Chem       Date:  2017-08-11       Impact factor: 4.142

2.  Fast venomic analysis of Crotalus durissus terrificus from northeastern Argentina.

Authors:  Luciano S Fusco; Emidio B Neto; Aleff F Francisco; Jorge Alfonso; Andreimar Soares; Daniel C Pimenta; Laura C Leiva
Journal:  Toxicon X       Date:  2020-06-15

3.  A Meta-Analysis of the Protein Components in Rattlesnake Venom.

Authors:  Anant Deshwal; Phuc Phan; Jyotishka Datta; Ragupathy Kannan; Suresh Kumar Thallapuranam
Journal:  Toxins (Basel)       Date:  2021-05-23       Impact factor: 4.546

4.  The relaxant effect of the Montivipera bornmuelleri snake venom on vascular contractility.

Authors:  Claudine Accary; Souad Hraoui-Bloquet; Riyad Sadek; Asma Alameddine; Ziad Fajloun; Jean-Claude Desfontis; Yassine Mallem
Journal:  J Venom Res       Date:  2016-02-23

5.  Isolation and characterization of Bradykinin potentiating peptides from Agkistrodon bilineatus venom.

Authors:  Aisha Munawar; Anum Zahid; Amr Negm; Ahmed Akrem; Patrick Spencer; Christian Betzel
Journal:  Proteome Sci       Date:  2016-01-14       Impact factor: 2.480

Review 6.  Harnessing the Natural Toxic Metabolites in COVID-19.

Authors:  Ali Bahrami; Mohammad Taheri; Mohammad Reza Arabestani; Meysam Soleimani; Mojdeh Mohammadi; Fatemeh Golabchi; Maryam Banitorfi; Seyed Mostafa Hosseini; Sodabe Khodabandehlou; Fatemeh Nouri
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-07       Impact factor: 2.629

Review 7.  Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19?

Authors:  Ahmed S Gouda; Bruno Mégarbane
Journal:  Drug Dev Res       Date:  2020-08-05       Impact factor: 5.004

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.